Delayed kinetics of tumor necrosis factor-mediated bystander lysis by peptide-specific CD8+ cytotoxic T lymphocytes

European Journal of Immunology

Volumn 28, Issue 12, 1998, Pages 4162-4169

  Smyth, Mark J ^a   Sedgwick, Jonathon D ^b  

^a AUSTIN RESEARCH INSTITUTE   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Bystander; Cytotoxicity; Fas ligand; Papilloma virus; TNF

Indexed keywords

CD8 ANTIGEN; FAS LIGAND; PERFORIN; TUMOR NECROSIS FACTOR; VIRUS ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GENETIC TRANSFECTION; LYMPHOBLAST; LYMPHOMA CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE; WART VIRUS;

EID: 0031770494     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1521-4141(199812)28:12<4162::aid-immu4162>3.0.co;2-e     Document Type: Article

References (47)

1. Kagi, D., Vignaux, F., Ledermann, B., Burki, K., Depraetere, V., Nagata, S., Hengartner, H. and Golstein, P., Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 1994. 265: 528-530.
2. Kojima, H., Shinohara, N., Hanaoka, S., Someya-Shirota, Y., Takagaki, Y., Ohno, H., Saito, T., Katayama, T., Yagita, H., Okumura, K., Shinkai, Y., Alt, F. W., Matsuzawa, A., Yonehara, S. and Takayama, H., Two distinct pathways of specific killing revealed by perforin mutant cytotoxic T lymphocytes. Immunity 1994. 1: 357-364.
3. Lowin, B., Hahne, M., Mattmann, C. and Tschopp, J., Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature 1994. 370: 650-652.
4. Henkart, P. A., Mechanism of lymphocyte-mediated cytotoxicity. Annu. Rev. Immunol. 1985. 3: 31-58.
5. Podack, E. R., Hengartner, H. and Lichtenheld, M. G., A central role of perforin in cytolysis? Annu. Rev. Immunol. 1991. 9: 129-157.
6. Smyth, M. J. and Trapani, J. A., Granzymes: exogenous proteinases that induce target cell apoptosis. Immunol. Today 1995. 16: 202-206.
7. Nagata, S. and Golstein, P., The Fas death factor. Science 1995. 267: 1449-1456.
8. Smith, C. A., Farrah, T. and Goodwin, R. G., The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 1994. 76: 959-962.
9. van den Broek, M. E., Kagi, D., Ossendorp, F., Toes, R., Vamvakas, S., Lutz, W. K., Melief, C. J., Zinkernagel, R. M. and Hengartner, H., Decreased tumor surveillance in perforin-deficient mice. J. Exp. Med. 1996. 184: 1781-1790.
10. Kagi, D., Ledermann, B., Burki, K., Seiler, P., Odermatt, B., Olsen, K. J., Podack, E. R., Zinkernagel, R. M. and Hengartner, H., Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforindeficient mice. Nature 1994. 369: 31-37.
11. Lowin, B., Beermann, F., Schmidt, A. and Tschopp, J., A null mutation in the perforin gene impairs cytolytic T lymphocyte- and natural killer cell-mediated cytotoxicity. Proc. Natl. Acad. Sci. USA 1994. 91: 11571-11575.
12. Walsh, C. M., Matloubian, M., Liu, C.-C., Ueda, R., Kurahara, C., Christensen, J., Huang, M. T. F., Young, J. D.-E., Ahmed, R. and Clark, W. R., Immune function in mice lacking the perforin gene. Proc. Natl. Acad. Sci. USA 1994. 91: 10854-10858.
13. Dhein, J., Walczak, H., Baumler, C., Debatin, K.-M. and Krammer, P. H., Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 1995. 373: 438-441.
14. Russell, J. H., Activation-induced death of mature T cells in the regulation of immune responses. Curr. Opin. Immunol. 1995. 7: 382-388.
15. Zheng, L., Fisher, G., Miller, R. E., Peschon, J., Lynch, D. H. and Lenardo, M. J., Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 1995. 377: 348-351.
16. + T cells. Nature 1995. 376: 181-184.
17. Rathmell, J. C., Townsend, S. E., Xu, J. C., Flavell, R. A. and Goodnow, C. C., Expansion or elimination of B cells in vivo: dual roles for CD40- and Fas (CD95)-ligands modulated by the B cell antigen receptor. Cell 1996. 87: 319-329.
18. Sytwu, H. K., Liblau, R. S. and McDevitt, H. O., The roles of Fas/Apo-1(CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice. Immunity 1996. 5: 17-30.
19. Duke, R. C., Self-recognition by T cells. I. Bystander killing of target cells bearing syngeneic MHC antigens. J. Exp. Med. 1989. 170: 59-71.
20. Dustin, M. L. and Springer, T. A., Role of lymphocyte adhesion receptors in transient interactions and cell locomotion. Annu. Rev. Immunol. 1991. 9: 27-66.
21. Hornung, F., Zheng, L. and Lenardo, M. J., Maintenance of clonotype specificity in CD95/Apo-1/Fas-mediated apoptosis of mature T lymphocytes. J. Immunol. 1997. 159: 3816-3822.
22. Smyth, M. J., Fas ligand-mediated bystander lysis of syngeneic cells in response to an allogeneic stimulus. J. Immunol. 1997. 158: 5765-5772.
23. + CTL. J. Immunol. 1997. 159: 2728-2734.
24. Qian, J. H., Titus, J. A., Andrew, S. M., Mezzanzanica, D., Garrido, M. A., Wunderlich, J. R. and Segal, D. M., Human peripheral blood lymphocytes targeted with bispecific antibodies release cytokines that are essential for inhibiting tumor growth. J. Immunol. 1991. 146: 3250-3256.
25. Koziel, M. J., Dudley, D., Afdhal, N., Grakoui, A., Rice, C. M., Choo, Q. L., Houghton, M. and Walker, B. D., HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release. J. Clin. Invest. 1995. 96: 2311-2321.
26. Braun, M. Y., Lowin, B., French, L., Acha-Orbea, H. and Tschopp, J., Cytotoxic T cells deficient in both functional fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease. J. Exp. Med. 1996. 183: 657-661.
27. Vassalli, P., The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 1992. 10: 411-452.
28. Sarin, A., Conan-Cibotti, M. and Henkart, P. A., Cytotoxic effect of TNF and lymphotoxin on T lymphoblasts. J. Immunol. 1995. 155: 3716-3718.
29. Ljunggren, H. G. and Karre, K., Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism. J. Exp. Med. 1985. 162: 1745-1759.
30. + cytotoxic T lymphocytes. J. Virol. 1998. 72: 5948-5954.
31. Ando, K., Hiroishi, K., Kaneko, T., Moriyama, T., Muto, Y., Kayagaki, N., Yagita, H., Okumura, K. and Imawari, M., Perform, Fas/Fas ligand, and TNF-α pathways as specific and bystander killing mechanisms of hepatitis C virus-specific human CTL. J. Immunol. 1997. 158: 5283-5291.
32. + T helper 1 effectors. J. Immunol. 1996. 157: 2961-2968.
33. + cytotoxic lymphocyte-mediated lysis. J. Immunol. 1993. 150: 4303-4314.
34. Lee, R. K., Spielman, J., Zhao, D. Y., Olsen, K. L. and Podack, E. R., Perform, Fas ligand, and tumor necrosis factor are the major cytotoxic molecules used by lymphokine-activated killer cells. J. Immunol. 1996. 157: 1919-1925.
35. Nishio, M., Spielman, J., Lee, R. K., Nelson, D. L. and Podack, E. R., CD80 (B7.1) and CD54 (intracellular adhesion molecule-1) induce target cell susceptibility to promiscuous cytotoxic T cell lysis. J. Immunol. 1996. 157: 4347-4353.
36. Schuurman, B., Heuff, G., Beelen, R. H. and Meyer, S., Enhanced human Kupffer cell-mediated cytotoxicity after activation of the effector cells and modulation of the target cells by interferon-gamma: a mechanistic study at the cellular level. Cell Immunol. 1995. 165: 141-147.
37. Grell, M., Douni, E., Wajant, H., Lohden, M., Clauss, M., Maxeiner, B., Georgopoulos, S., Lesslauer, W., Kollias, G., Pfizenmaier, K. and Scheurich, P., The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 1995. 83: 793-802.
38. Schneider, P., Holler, N., Bodmer, J. L., Hahne, M., Frei, K., Fontana, A. and Tschopp, J., Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. J. Exp. Med. 1998. 187: 1205-1213.
39. Browning, J. L., Sizing, I. D., Lawton, P., Bourdon, P. R., Rennert, P. D., Majeau, G. R., Ambrose, C. M., Hession, C., Miatkowski, K., Griffiths, D. A., Ngamek, A., Meier, W., Benjamin, C. D. and Hochman, P. S., Characterization of lymphotoxin-alpha beta complexes on the surface of mouse lymphocytes. J. Immunol. 1997. 159: 3288-3298.
40. Wiley, S. R., Schooley, K., Smolak, P. J., Din, W. S., Huang, C. P., Nicholl, J. K., Sutherland, G. R., Smith, T. D., Rauch, C., Smith, C. A. and Goodwin, R. G., Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 1995. 3: 673-682.
41. Leist, M., Gantner, F., Bohlinger, I., Germann, P. G., Tiegs, G. and Wendel, A., Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-α requires transcriptional arrest. J. Immunol. 1994. 153: 1778-1788.
42. Korner, H., Riminton, D. S., Strickland, D. H., Lemckert, F. A., Pollard, J. D. and Sedgwick, J. D., Critical points of tumor necrosis factor action in central nervous system autoimmune inflammation defined by gene targeting. J. Exp. Med. 1997. 186: 1585-1590.
43. Korner, H., Cook, M., Riminton, D. S., Lemckert, F. A., Hoek, B., Ledermann, B., Kontgen, F., Fazekas de St Groth, B. and Sedgwick, J. D., Distinct roles for lymphotoxin-α and tumour necrosis factor in lymphoid organogenesis and spatial organisation defined in gene targeted C57BL/6 mice. Eur. J. Immunol. 1997. 27: 2600-2609.
44. Zhu, X., Tommasino, M., Vousden, K., Sadovnikava, E., Rappuoli, R., Crawford, L., Kast, M., Melief, C. J., Beverley, P. C. and Stauss, H. J., Both immunization with protein and recombinant vaccinia virus can stimulate CTL specific for the E7 protein of human papilloma virus 16 in H-2d mice. Scand. J. Immunol. 1995. 42: 557-563.
45. Kent, S. B. H. and Hood, L. E. A. N., A novel approach to automated peptide synthesis based on new insight into solid phase chemistry. In Izumiya, J. (Ed.) Peptides Chemistry. Protein Research Foundation, Osaka 1985, p 217.
46. Smyth, M. J., Sutton, V. R., Kershaw, M. H. and Trapani, J. A., Xenospecific cytotoxic T lymphocytes use perforin- and Fas-mediated lytic pathways. Transplantation 1996. 62: 1529-1532.
47. 2+-independent T cell-mediated cytotoxicity. J. Exp. Med. 1993. 177: 195-200.